HUT59935A - Process for producing o-methyl-derivatives of azitormycin a and pharmaceutical compositions containing them as active components - Google Patents
Process for producing o-methyl-derivatives of azitormycin a and pharmaceutical compositions containing them as active componentsInfo
- Publication number
- HUT59935A HUT59935A HU912408A HU240891A HUT59935A HU T59935 A HUT59935 A HU T59935A HU 912408 A HU912408 A HU 912408A HU 240891 A HU240891 A HU 240891A HU T59935 A HUT59935 A HU T59935A
- Authority
- HU
- Hungary
- Prior art keywords
- azitormycin
- derivatives
- methyl
- producing
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9202619A HU215158B (hu) | 1990-07-18 | 1991-07-18 | Eljárás egy azitromicin A O-benziloxi-karbonil-származék előállítására |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
YU140990 | 1990-07-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
HU912408D0 HU912408D0 (en) | 1991-12-30 |
HUT59935A true HUT59935A (en) | 1992-07-28 |
Family
ID=25554060
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9202619A HU215158B (hu) | 1990-07-18 | 1991-07-18 | Eljárás egy azitromicin A O-benziloxi-karbonil-származék előállítására |
HU912408A HUT59935A (en) | 1990-07-18 | 1991-07-18 | Process for producing o-methyl-derivatives of azitormycin a and pharmaceutical compositions containing them as active components |
HU9802439A HU221803B1 (hu) | 1990-07-18 | 1991-07-18 | Azitromicin A O-benziloxi-karbonil-származék és savaddíciós sói |
HU95P/P00748P HU211659A9 (en) | 1990-07-18 | 1995-07-03 | O-methyl derivatives of azithromycin a |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9202619A HU215158B (hu) | 1990-07-18 | 1991-07-18 | Eljárás egy azitromicin A O-benziloxi-karbonil-származék előállítására |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9802439A HU221803B1 (hu) | 1990-07-18 | 1991-07-18 | Azitromicin A O-benziloxi-karbonil-származék és savaddíciós sói |
HU95P/P00748P HU211659A9 (en) | 1990-07-18 | 1995-07-03 | O-methyl derivatives of azithromycin a |
Country Status (20)
Country | Link |
---|---|
US (1) | US5250518A (hu) |
EP (1) | EP0467331B1 (hu) |
JP (1) | JP2657132B2 (hu) |
CN (1) | CN1029738C (hu) |
AT (1) | ATE129715T1 (hu) |
BG (1) | BG60593B1 (hu) |
CA (1) | CA2046956C (hu) |
CZ (1) | CZ280640B6 (hu) |
DE (1) | DE69114198T2 (hu) |
DK (1) | DK0467331T3 (hu) |
ES (1) | ES2081397T3 (hu) |
GR (1) | GR3018330T3 (hu) |
HR (1) | HRP920491B1 (hu) |
HU (4) | HU215158B (hu) |
PL (1) | PL166379B1 (hu) |
RO (1) | RO109338B1 (hu) |
RU (1) | RU2045533C1 (hu) |
SI (1) | SI9011409A (hu) |
SK (1) | SK279075B6 (hu) |
UA (1) | UA27105A1 (hu) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP930014A2 (en) * | 1993-01-08 | 1994-08-31 | Pliva Pharm & Chem Works | 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates |
HRP931480B1 (en) * | 1993-12-08 | 1997-08-31 | Sour Pliva | 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A |
US5605889A (en) * | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
ES2279242T3 (es) * | 1997-10-16 | 2007-08-16 | Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. | Nuevos 3,6-hemicetales de la clase de las 9a-azalidas. |
US6861411B1 (en) | 1997-12-02 | 2005-03-01 | Pfizer, Inc. | Method of treating eye infections with azithromycin |
TW546302B (en) * | 1998-05-08 | 2003-08-11 | Biochemie Sa | Improvements in macrolide production |
UA70972C2 (uk) | 1998-11-20 | 2004-11-15 | Пфайзер Продактс Інк. | 13-членні азаліди і їх застосування як антибіотиків |
HRP980646B1 (en) * | 1998-12-30 | 2008-02-29 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | Novel oleandomycin derivatives |
US7056893B2 (en) | 1999-03-31 | 2006-06-06 | Insite Vision, Inc. | Topical treatment for prevention of ocular infections |
US6239113B1 (en) | 1999-03-31 | 2001-05-29 | Insite Vision, Incorporated | Topical treatment or prevention of ocular infections |
HRP990116B1 (en) * | 1999-04-20 | 2007-10-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | NOVEL 8a AND 9a- 15-MEMBERED LACTAMES |
US6465437B1 (en) * | 1999-06-30 | 2002-10-15 | Pfizer Inc. | Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition |
US6787342B2 (en) | 2000-02-16 | 2004-09-07 | Merial Limited | Paste formulations |
CA2419873A1 (en) | 2000-08-23 | 2002-02-28 | Wockhardt Limited | Process for preparation of anhydrous azithromycin |
HRP20010301A2 (en) * | 2001-04-27 | 2001-12-31 | Pliva D D | New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases |
US7271154B2 (en) | 2002-02-15 | 2007-09-18 | Merckle Gmbh | Antibiotic conjugates |
AU2003215245A1 (en) | 2002-02-15 | 2003-09-09 | Sympore Gmbh | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
AU2003219770B2 (en) | 2002-02-15 | 2008-10-09 | Merckle Gmbh | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
ITMI20022292A1 (it) * | 2002-10-29 | 2004-04-30 | Zambon Spa | 9a-azalidi ad attivita' antiinfiammatoria. |
US7435805B2 (en) | 2003-05-30 | 2008-10-14 | Glaxpsmithkline Istrazivacki | O-alkyl macrolide and azalide derivatives and regioselective process for their preparation |
AU2003264910A1 (en) * | 2003-05-30 | 2005-01-21 | Pliva - Istrazivacki Institut D.O.O. | Process for selective alkylation of macrolide and azalide derivatives |
WO2005021567A1 (en) * | 2003-09-02 | 2005-03-10 | Pliva - Istrazivacki Institut D.O.O. | O-alkyl macrolide and azalide derivatives and regioselective process for their preparation |
US7468428B2 (en) | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
US8080529B2 (en) * | 2005-01-13 | 2011-12-20 | Glaxo Group Limited | Macrolides with anti-inflammatory activity |
US8362086B2 (en) | 2005-08-19 | 2013-01-29 | Merial Limited | Long acting injectable formulations |
EP2384332A1 (en) | 2009-01-30 | 2011-11-09 | Glaxo Group Limited | 9-deoxo- 9a-methyl- 9a- aza- 9a-h0m0erythr0mycin a derivatives for the treatment of neutrophil dominated inflammatory diseases |
MA32997B1 (fr) * | 2009-01-30 | 2012-01-02 | Glaxo Group Ltd | Macrolide anti-inflammatoire |
CN101830949B (zh) * | 2009-03-13 | 2012-05-23 | 上海医药工业研究院 | 一种阿奇霉素衍生物、其中间体及其制备方法和应用 |
WO2011131749A1 (en) | 2010-04-23 | 2011-10-27 | Glaxo Group Limited | New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases |
CN102952166A (zh) * | 2011-08-28 | 2013-03-06 | 山东方明药业集团股份有限公司 | 聚合物支载硼氢阴离子还原剂合成阿奇霉素中间体的方法 |
WO2013148874A1 (en) | 2012-03-27 | 2013-10-03 | Burnet Michael W | Anti-inflammatory macrolides |
GB201608236D0 (en) | 2016-05-11 | 2016-06-22 | Fidelta D O O | Seco macrolide compounds |
WO2018193117A1 (en) * | 2017-04-20 | 2018-10-25 | Novintum Biotechnology Gmbh | Azithromycin derivatives containing a phosphonium ion as anticancer agents |
JP2020517749A (ja) * | 2017-04-20 | 2020-06-18 | ライジング タイド ファウンデーション | 抗がん剤としてホスホニウムイオンを含むアジスロマイシン誘導体 |
WO2018195446A1 (en) | 2017-04-21 | 2018-10-25 | Lisanti Michael P | Targeting hypoxic cancer stem cells (cscs) with doxycycline: implications for improving anti-angiogenic therapy |
CA3060510A1 (en) | 2017-04-21 | 2018-10-25 | Lunella Biotech, Inc. | Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs) |
EP3624897A4 (en) | 2017-05-19 | 2021-07-14 | Lunella Biotech, Inc. | COMPANION DIAGNOSIS FOR MITOCHONDRIAL INHIBITORS |
CA3063717C (en) | 2017-05-19 | 2021-08-24 | Lunella Biotech, Inc. | Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells |
AU2018292283B2 (en) | 2017-06-26 | 2020-07-23 | Lunella Biotech, Inc. | Mitoketoscins: mitochondrial-based therapeutics targeting ketone metabolism in cancer cells |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4474768A (en) * | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
JPS61103890A (ja) * | 1984-10-26 | 1986-05-22 | Taisho Pharmaceut Co Ltd | 6−0−メチルエリスロマイシンa誘導体 |
EP0184921A3 (en) * | 1984-12-08 | 1986-10-29 | Beecham Group Plc | Erythromycin derivatives |
US4833236A (en) * | 1986-05-02 | 1989-05-23 | Taisho Pharmaceutical Co., Ltd. | Erythromycin derivatives |
WO1989002271A1 (en) * | 1987-09-10 | 1989-03-23 | Pfizer | Azithromycin and derivatives as antiprotozoal agents |
-
1990
- 1990-07-18 SI SI9011409A patent/SI9011409A/sl not_active IP Right Cessation
-
1991
- 1991-07-06 SK SK2195-91A patent/SK279075B6/sk unknown
- 1991-07-12 CA CA002046956A patent/CA2046956C/en not_active Expired - Fee Related
- 1991-07-16 RO RO148016A patent/RO109338B1/ro unknown
- 1991-07-16 CZ CS912195A patent/CZ280640B6/cs not_active IP Right Cessation
- 1991-07-17 DK DK91111948.5T patent/DK0467331T3/da active
- 1991-07-17 EP EP91111948A patent/EP0467331B1/en not_active Expired - Lifetime
- 1991-07-17 ES ES91111948T patent/ES2081397T3/es not_active Expired - Lifetime
- 1991-07-17 BG BG94837A patent/BG60593B1/bg unknown
- 1991-07-17 UA UA5001127A patent/UA27105A1/uk unknown
- 1991-07-17 AT AT91111948T patent/ATE129715T1/de not_active IP Right Cessation
- 1991-07-17 DE DE69114198T patent/DE69114198T2/de not_active Expired - Fee Related
- 1991-07-17 RU SU915001127A patent/RU2045533C1/ru not_active IP Right Cessation
- 1991-07-18 HU HU9202619A patent/HU215158B/hu unknown
- 1991-07-18 HU HU912408A patent/HUT59935A/hu unknown
- 1991-07-18 CN CN91104907A patent/CN1029738C/zh not_active Expired - Fee Related
- 1991-07-18 HU HU9802439A patent/HU221803B1/hu not_active IP Right Cessation
- 1991-07-18 PL PL91291130A patent/PL166379B1/pl not_active IP Right Cessation
- 1991-07-18 JP JP3178514A patent/JP2657132B2/ja not_active Expired - Fee Related
- 1991-07-18 US US07/731,781 patent/US5250518A/en not_active Expired - Lifetime
-
1992
- 1992-09-25 HR HRP-1409/90A patent/HRP920491B1/xx not_active IP Right Cessation
-
1995
- 1995-07-03 HU HU95P/P00748P patent/HU211659A9/hu unknown
- 1995-12-07 GR GR950403439T patent/GR3018330T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CZ280640B6 (cs) | 1996-03-13 |
GR3018330T3 (en) | 1996-03-31 |
CN1029738C (zh) | 1995-09-13 |
HU9202619D0 (en) | 1992-12-28 |
RU2045533C1 (ru) | 1995-10-10 |
HRP920491A2 (en) | 1994-08-31 |
HU9802439D0 (en) | 1998-12-28 |
PL166379B1 (en) | 1995-05-31 |
BG60593B1 (bg) | 1995-09-29 |
US5250518A (en) | 1993-10-05 |
CA2046956C (en) | 1999-01-05 |
ES2081397T3 (es) | 1996-03-01 |
DE69114198T2 (de) | 1996-06-27 |
JP2657132B2 (ja) | 1997-09-24 |
CA2046956A1 (en) | 1992-01-19 |
HRP920491B1 (en) | 1998-10-31 |
EP0467331B1 (en) | 1995-11-02 |
CS219591A3 (en) | 1992-03-18 |
HU221803B1 (hu) | 2003-01-28 |
SI9011409A (en) | 1995-10-31 |
HU215158B (hu) | 1998-12-28 |
ATE129715T1 (de) | 1995-11-15 |
SK279075B6 (sk) | 1998-06-03 |
PL291130A1 (en) | 1992-11-16 |
HUT62307A (en) | 1993-04-28 |
CN1059728A (zh) | 1992-03-25 |
DK0467331T3 (da) | 1996-02-05 |
EP0467331A1 (en) | 1992-01-22 |
RO109338B1 (ro) | 1995-01-30 |
BG94837A (bg) | 1993-12-24 |
DE69114198D1 (de) | 1995-12-07 |
HU912408D0 (en) | 1991-12-30 |
JPH05132497A (ja) | 1993-05-28 |
UA27105A1 (uk) | 2000-02-28 |
HU211659A9 (en) | 1995-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT59935A (en) | Process for producing o-methyl-derivatives of azitormycin a and pharmaceutical compositions containing them as active components | |
HUT36840A (en) | Process for producing 11-beta-estradiene derivatives and pharmaceutical compositions containing them | |
TW341573B (en) | New erythromycin derivatives, their preparation process and their use as medicaments | |
AU2344195A (en) | Acylated aminophenylsulphonylureas, process for their preparation and their use as herbicides and plant-growth regulators | |
AU656466B2 (en) | New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them | |
IE892794L (en) | Disubstituted benzylamines, their preparation process, their¹use as medicine and their synthesising agents | |
ZA919030B (en) | Compounds of n-benzoyl proline,process for their preparation and pharmaceutical compositions containing them | |
HUT37631A (en) | Process for producing 6,6-ethylene-15,16-methylene-3-oxo.17-alpha-pregn-4-ene-21,17-carbolavtones and pharmaceutical compositions containing them | |
JPS57106695A (en) | Anthracycline g lycoside compound | |
TW336235B (en) | 3'-aziridino-anthracycline derivatives, process for preparating them and pharmaceutical composition containing them | |
ZA912618B (en) | 3-aminochroman derivatives,process for preparing these and pharmaceutical compositions containing them | |
ZA932359B (en) | 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them | |
HUT50142A (en) | Process for producing allyl-mercapto-acetyl-sidnonimine derivatives and pharmaceutical compositions containing them | |
DK0457090T3 (da) | Fremgangsmåde til fremstilling af 3-amino-2-(het)-aroyl-acrylsyrederivater | |
ATE30714T1 (de) | Neue aminoalkohole, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel und zwischenprodukte. | |
DE3569528D1 (en) | Penem derivatives, methods of producing them, their use and pharmaceutical compositions | |
ATE59637T1 (de) | Neue basisch substituierte pyridinverbindungen, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung. | |
ES8604720A1 (es) | Un procedimiento para la preparacion de derivados de piperi-dina | |
CA2137889A1 (fr) | Nouveaux analogues de l'eburnane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
TW330205B (en) | A process for preparing loracarbef monohydrate | |
GR3000773T3 (en) | 2,2;6,6-diethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactones, process for their preparation and pharmaceutical compositions containing them | |
ZA924888B (en) | Process for the synthesis of enantiomers of 3-aminochroman compounds | |
ES8107249A1 (es) | Un procedimiento para la preparacion de derivados de 2-epi- fortimicina. | |
DE3372963D1 (en) | Novel aminonaphthacene derivatives and process for preparation thereof | |
HUT50127A (en) | Process for producing compounds of antiarrythmic activity and pharmaceutical compositions containing |